Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A novel mechanism of action for hypertension control: Moxonidine as a selective I1-imidazoline agonist

Cardiovascular Drugs and Therapy(1994)10.1007/bf00877082Source: DataRank Database

A novel mechanism of action for hypertension control: Moxonidine as a selective I1-imidazoline agonist is a research paper published in Cardiovascular Drugs and Therapy (1994). On theSindex it has a DataRank of 3.4. It has been cited 65 times, with 56 citing works in its 1-hop citation network.

N/A

3.4DataRank · unranked

Scored on demand from live citation data

65 citations · 56 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.79)OA: closedTopics (61)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 18%Citation Network 82%

Base Score Contribution

0.628

From this paper's citation signal

Citation Network Contribution

2.8

From 48 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (9)

Musa A. Haxhiu,Lynette M. Graff,Laura A. Collins,Ismail Dreshaj,Danette L. Grove

Live enrichment

PubMed:8068578 OpenAlex:https://openalex.org/W2004140319

NHLBI NIH HHS

Grant: HL44514

FWCI

2.79

Citation Percentile

0.9%

Citation Trend

2012

2013

2017

2018

2019

2020

2021

closedLicense: http://www.springer.com/tdm

publisherhttp://link.springer.com/content/pdf/10.1007/BF00877082.pdf

publisherhttp://link.springer.com/article/10.1007/BF00877082/fulltext.html

publisherhttp://link.springer.com/content/pdf/10.1007/BF00877082

journalhttps://doi.org/10.1007/bf00877082

repositoryhttps://pubmed.ncbi.nlm.nih.gov/8068578

Fields of Study

Receptor Mechanisms and SignalingNeuroscience of respiration and sleepNeurotransmitter Receptor Influence on BehaviorAdrenal MedullaAnimalsAntihypertensive AgentsAutoradiographyBinding SitesBlood PressureCattleCells, CulturedClonidineHumansHypertensionImidazolesImidazoline ReceptorsMedulla OblongataOxazolesRatsRats, Inbred SHRReceptors, Adrenergic, alphaReceptors, DrugRilmenidine

MeSH Terms

RilmenidineAdrenal MedullaAnimalsAntihypertensive AgentsAutoradiographyBinding SitesBlood PressureCattleCells, CulturedClonidineHumansHypertensionImidazolesMedulla OblongataOxazolesRats, Inbred SHRReceptors, Adrenergic, alphaReceptors, DrugRatsImidazoline Receptors

Keywords

MoxonidineImidazoline receptorRilmenidineRostral ventrolateral medullaAgonistClonidineReceptorPharmacologyMechanism of actionEndocrinologyMedicineSympathoadrenal systemInternal medicineMedulla oblongataCentral nervous systemChemistryCatecholamineBiochemistry

Sustainable Development Goals

SDG 0: Good health and well-being